These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33429029)

  • 21. A Proposed COVID-19 Testing Algorithm.
    Hart A; Bortolin M; Awoniyi O; Alhajjaj F; Ciottone GR
    Disaster Med Public Health Prep; 2020 Oct; 14(5):e11-e15. PubMed ID: 32576313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of the U.S. response to COVID-19 in Global Health.
    Leineweber FV; Bermudez JAZ
    Cien Saude Colet; 2021 Mar; 26(3):1001-1012. PubMed ID: 33729354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 testing of pregnant women in Japan.
    Orisaka M; Kawamura H; Yoshida Y
    J Obstet Gynaecol Res; 2021 Jan; 47(1):464. PubMed ID: 33169489
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluating tests for diagnosing COVID-19 in the absence of a reliable reference standard: pitfalls and potential solutions.
    Korevaar DA; Toubiana J; Chalumeau M; McInnes MDF; Cohen JF
    J Clin Epidemiol; 2021 Oct; 138():182-188. PubMed ID: 34358639
    [No Abstract]   [Full Text] [Related]  

  • 25. In September 2020, the World Health Organization called for 'equitable access to COVID-19 tools' which included 'the development, production and equitable access to COVID-19 tests, treatments and vaccines globally, while strengthening health systems'. What evidence is there of inequity of access so far in this pandemic? What is the role of national governments and of the WHO in this?
    Osborne R
    Med Confl Surviv; 2021 Sep; 37(3):187-196. PubMed ID: 34547947
    [No Abstract]   [Full Text] [Related]  

  • 26. Trends of Epidemiological and Demographic Indicators of COVID-19 in India.
    Gupta MK; Bhardwaj P; Goel AD; Saurabh S; Misra S
    J Infect Dev Ctries; 2021 May; 15(5):618-624. PubMed ID: 34106883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges to testing COVID-19 in conflict zones: Yemen as an example.
    Dhabaan GN; Al-Soneidar WA; Al-Hebshi NN
    J Glob Health; 2020 Jun; 10(1):010375. PubMed ID: 32582438
    [No Abstract]   [Full Text] [Related]  

  • 28. Limiting Patient Autonomy: Mandatory COVID-19 Diagnostic Testing.
    Ruhnke GW
    J Hosp Med; 2021 May; 16(5):313-315. PubMed ID: 33734984
    [No Abstract]   [Full Text] [Related]  

  • 29. In September 2020, the World Health Organization called for 'equitable access to COVID-19 tools' which included 'the development, production and equitable access to COVID-19 tests, treatments and vaccines globally, while strengthening health systems'. What evidence is there of inequity of access so far in this pandemic? What is the role of national governments and of the WHO in this?
    Roberts H
    Med Confl Surviv; 2021 Sep; 37(3):197-204. PubMed ID: 34433336
    [No Abstract]   [Full Text] [Related]  

  • 30. Conflict and COVID-19 in Yemen: beyond the humanitarian crisis.
    Alsabri M; Alhadheri A; Alsakkaf LM; Cole J
    Global Health; 2021 Jul; 17(1):83. PubMed ID: 34294097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interoperability: COVID-19 as an Impetus for Change.
    Greene DN; McClintock DS; Durant TJS
    Clin Chem; 2021 Mar; 67(4):592-595. PubMed ID: 33475729
    [No Abstract]   [Full Text] [Related]  

  • 32. Wisely choosing the numbers during the pandemic.
    Kambhampati SBS; Vaishya R
    Diabetes Metab Syndr; 2020; 14(6):1895. PubMed ID: 33002781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 and influenza testing in New York City.
    Takahashi M; Egorova NN; Kuno T
    J Med Virol; 2021 Feb; 93(2):698-701. PubMed ID: 32910466
    [No Abstract]   [Full Text] [Related]  

  • 34. Morgue data hint at COVID's true toll in Africa.
    Kreier F
    Nature; 2022 Mar; 603(7903):778-779. PubMed ID: 35322222
    [No Abstract]   [Full Text] [Related]  

  • 35. COVID-19 Response and Complex Emergencies: The Case of Yemen.
    Ali Maher O; Pichierri G; Farina G; Panu Napodano CM; Bellizzi S
    Disaster Med Public Health Prep; 2020 Aug; 14(4):e27-e28. PubMed ID: 32713416
    [No Abstract]   [Full Text] [Related]  

  • 36. Underdetection of cases of COVID-19 in France threatens epidemic control.
    Pullano G; Di Domenico L; Sabbatini CE; Valdano E; Turbelin C; Debin M; Guerrisi C; Kengne-Kuetche C; Souty C; Hanslik T; Blanchon T; Boëlle PY; Figoni J; Vaux S; Campèse C; Bernard-Stoecklin S; Colizza V
    Nature; 2021 Feb; 590(7844):134-139. PubMed ID: 33348340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Outcomes for Patients With Anosmia 1 Year After COVID-19 Diagnosis.
    Renaud M; Thibault C; Le Normand F; Mcdonald EG; Gallix B; Debry C; Venkatasamy A
    JAMA Netw Open; 2021 Jun; 4(6):e2115352. PubMed ID: 34165581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mass testing for covid-19 in the UK.
    Gill M; Gray M
    BMJ; 2020 Nov; 371():m4436. PubMed ID: 33199289
    [No Abstract]   [Full Text] [Related]  

  • 39. Understanding varying COVID-19 mortality rates reported in Africa compared to Europe, Americas and Asia.
    Okonji EF; Okonji OC; Mukumbang FC; Van Wyk B
    Trop Med Int Health; 2021 Jul; 26(7):716-719. PubMed ID: 33733568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Containing SARS-CoV-2 in hospitals facing finite PPE, limited testing, and physical space variability: Navigating resource constrained enhanced traffic control bundling.
    De Georgeo MR; De Georgeo JM; Egan TM; Klee KP; Schwemm MS; Bye-Kollbaum H; Kinser AJ
    J Microbiol Immunol Infect; 2021 Feb; 54(1):4-11. PubMed ID: 32773286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.